NCT07228533

Brief Summary

This study will develop and evaluate a mobile-based co-design intervention (CesiKids) to enhance psychosocial resilience in hospitalized adolescents aged 12-18 diagnosed with cancer. The program will be created using Bronfenbrenner's Ecological Systems Theory and designed in collaboration with nurses, recovered adolescents, and parents. A randomized controlled design will be used. The intervention group will participate in a four-week structured program, while the control group will receive standard care. Psychosocial resilience and coping outcomes will be assessed at baseline, post-intervention, and follow-up. This research aims to offer an evidence-based, scalable model to support resilience among adolescents with cancer in clinical settings.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Nov 2025Jun 2027

Study Start

First participant enrolled

November 1, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 14, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

1.2 years

First QC Date

November 13, 2025

Last Update Submit

November 13, 2025

Conditions

Keywords

AdolescentResilienceCoping skillsNeoplasmsPediatric nursingMobile applicationPsychosocial intervention

Outcome Measures

Primary Outcomes (1)

  • Child and Youth Resilience Measure (CYRM-R)

    The Child and Youth Resilience Measure-Revised (CYRM-R) is a multidimensional scale based on the socio-ecological model to assess resilience. The 28-item original version was developed by Liebenberg, Ungar, and Van de Vijver through the International Resilience Project. Later, Liebenberg, Ungar, and LeBlanc created a 12-item short form with three subscales: individual, relational, and contextual resilience. Factor loadings ranged from .39-.88, and Cronbach's alpha was .84. Items are rated on a five-point Likert scale (1-5), with higher scores indicating greater resilience. The Turkish adaptation by Arslan showed strong reliability (α = .91; item-total correlations = .45-.79). In this study, the CYRM-R will assess changes in adolescents' resilience after the CesiKids program.

    Baseline (prior to intervention), immediately post-intervention (within 1 week after completion), 3 months post-intervention, and 6 months post-intervention

Secondary Outcomes (1)

  • Pediatric Cancer Coping Scale (PCCS)

    Baseline (prior to intervention), immediately post-intervention (within 1 week after completion), 3 months post-intervention, and 6 months post-intervention

Study Arms (2)

Standard Psychosocial Care Group

NO INTERVENTION

Participants in this arm will receive standard psychological care routinely provided within the pediatric oncology clinic. No additional structured digital intervention or psychological resilience-based program will be administered. Standard support, including routine clinical communication and psychological services offered by the healthcare team, will continue as usual during the study period.

CesiKids Intervention Group

EXPERIMENTAL

Participants in this group will receive the CesiKids program, a mobile-based psychological resilience intervention specifically developed for adolescents diagnosed with cancer. The program includes AI-supported guidance and interventions and consists of a total of four modules delivered over four weeks, with two structured sessions per module (eight sessions in total). Participants' engagement with the program and their assessment outcomes will be evaluated to determine the feasibility and effectiveness of the CesiKids intervention in enhancing psychological resilience and coping skills among adolescents with cancer.

Other: CesiKids Mobile-Based Psychological Resilience Program

Interventions

The CesiKids Program will be a nurse-led, AI-supported mobile intervention to enhance psychological resilience in adolescents diagnosed with cancer. Grounded in Bronfenbrenner's Bioecological Theory, it will address interactions between adolescents and their family, peers, and clinical environments. Developed through a co-design process with nurses, recovered adolescents, and parents, the program will include AI-driven adaptive feedback and emotional support features. Delivered over four weeks with structured digital sessions, CesiKids will promote emotional regulation, coping, and resilience through interactive storytelling, reflection, and personalized guidance. This integrative model will combine ecological principles, AI personalization, and participatory design to create an innovative psychosocial care approach for hospitalized adolescents with cancer.

Also known as: CesiKids Psychological Resilience Intervention, CesiKids Mobile Application, CesiKids Program
CesiKids Intervention Group

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Parents have provided informed consent after receiving information,
  • The child has given assent to participate after being informed,
  • The child is between 12 and 18 years of age,
  • The child has been diagnosed with cancer and is currently receiving inpatient treatment,
  • The child is undergoing chemotherapy and/or radiotherapy,
  • The child is able to use a computer and/or smartphone,
  • The child can understand and speak Turkish.

You may not qualify if:

  • Receiving hematopoietic stem cell transplantation treatment,
  • Having developed a relapse after remission,
  • Experiencing communication difficulties (e.g., intellectual disability, visual impairment, etc.),
  • Having a psychiatric diagnosis made by a psychiatrist,
  • Having experienced a significant life event affecting psychological well-being within the past four weeks (e.g., death, divorce, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University Faculty of Medicine Cebeci Research and Practice Hospital

Ankara, Ankara, 06620, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Ayfer AÇIKGÖZ, PhD

    Eskişehir Osmangazi University Faculty of Health Sciences

    STUDY DIRECTOR

Central Study Contacts

Sibel DAĞLIYAR, Master's Degree (PhD Student)

CONTACT

Ayfer AÇIKGÖZ, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Since the study will be conducted by the principal investigator, investigator blinding will not be possible. Additionally, because the study will be carried out with hospitalized adolescents and the intervention and control groups will be present in the clinic simultaneously, participant blinding cannot be implemented. To prevent potential bias in group allocation, the randomization table will be generated by an independent statistician. Data analysis and reporting will also be conducted by the same independent statistician, ensuring blinding at the statistical analysis stage.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study is a randomized controlled trial with a parallel assignment design. Participants will be randomly assigned to either the intervention or control group and followed concurrently. Adolescents in the intervention group will participate in the four-week CesiKids mobile psychosocial resilience program, while the control group will receive standard clinical care. No crossover between groups will occur.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

November 13, 2025

First Posted

November 14, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

November 14, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to privacy and confidentiality concerns. The dataset contains sensitive clinical and psychological information of adolescent patients with cancer, and data sharing could risk participant identification. Only aggregated and anonymized results will be reported in publications.

Locations